STADA is a leading manufacturer of high-quality pharmaceuticals. With its long heritage rooted in pharmacies, the company has been on the market for over 125 years and is recognized as a reliable and trustworthy partner. With STADA products, people can protect their health and regain a dignified and fulfilling life. With proven generics, the company ensures that everyday health is affordable. STADA also creates an attractive work environment for its employees, where they have the opportunity for personal development.
STADA focuses on three main areas: consumer health products, generics and specialty pharmaceuticals. STADA Arzneimittel AG distributes its products in more than 120 countries. Consumer Healthcare brands such as Zoflora®, Snup®, Nizoral® and Grippostad® are the sales leaders in their product categories. In fiscal year 2022, the STADA Group generated total sales of €3,797.2 million and earnings before interest, taxes, depreciation and amortization (EBITDA) reached €884.7 million. At the end of 2022, STADA employed 13,183 people worldwide.